Ex parte PERGOLIZZI et al. - Page 5




          Appeal No. 95-3606                                                          
          Application 07/827,691                                                      
          11, 15, 27, 6, 9, 34, and 35 are identical in scope to the                  
          materials combined to form the kits of Claims 42 and 29 to 33.              
          We hold that the scope of materials employed to perform the                 
          methods appellants claim is not commensurate with the scope of              
          materials combined to form the kits appellants claim.                       
          Specifically, method step b) of Claim 41 reads in relevant                  
          part (emphasis added):                                                      
                    b)   amplifying a nucleic acid in said nucleic acid               
               sample by performing a polymerase chain reaction in a                  
               reaction mixture that is substantially free of GTP and                 
               dGTP . . . .                                                           
          In contrast, kit component c) of Claim 42 is (emphasis added):              
                    c)   a PCR reaction mixture which is substantially                
               free of added GTP or dGTP.                                             
          Thus, while the PCR reaction mixture of the method of Claim 41              
          must be “substantially free” of both GTP and dGTP, the                      
          reaction mixture included in the kit of Claim 42 need not be                
          substantially free of both GTP and dGTP and can be used in                  
          methods outside the scope of Claim 41, which, though                        
          nonpreferred, applicants nevertheless regard as their                       
          invention.  See applicants’ specification (Spec.), page 19,                 
          lines 12-15; emphasis added):                                               
                    In addition to using an analogue of guanosine, it is              
               further preferred that the method of the present                       
          invention                                                                   
                                          - 5 -                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007